Sweden updates medtech software regs guidance to “clarify ambiguities”
This article was originally published in Clinica
Executive Summary
The Swedish Medical Products Agency (Läkemedelsverket, or MPA) has issued updated guidance on the regulation of standalone software with a medical purpose that qualify as medical devices, to reflect issues that have arisen in relation to such products in recent years as a result of the rapid development of the field and to clarify "remaining ambiguities".
You may also be interested in...
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.
Global Medtech Guidance Tracker: March 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-nine documents have been posted on the tracker since its last update.